Black fungus: Karnataka forms expert panel, asks for report on prevention

A facility to treat those with black fungus was opened in Bengaluru and will be set up in six other cities in Karnataka.
A COVID19 patient being treated my a medical staff wearing PPE kit in India inside a hospital
A COVID19 patient being treated my a medical staff wearing PPE kit in India inside a hospital
Written by:

Karnataka Health Minister Dr Sudhakar K on Monday announced that an expert panel has been set up to study the black fungus (Mucormycosis) in the state. Sudhakar said that the panel will submit a report on the black fungus and recommendations on how to curb its spread. He made the announcement after the treatment facility at state-run Bowring Hospital in Bengaluru was opened on May 17. "The panel has been set up to ascertain the cause of the infection in patients post COVID-19 treatment,” the minister told the reporters. The fungal infection, caused by a group of molds called mucormycetes, is emerging as a post-COVID-19 complication across the country. Observing that the fungus enters through the nasal cavity in humans, the Minister noted that water used in humidifiers in hospitals where COVID-19 patients are being treated is also a cause for the spread of infection.

Patients who were administered steroids and have diabetes are vulnerable to the infection. The minister had earlier cautioned those with immune-compromised conditions like HIV as they are prone to contract the infection too.
At Bowring hospital, patients affected with Mucormycosis are given Amphotericin injection. one needs 40-60 vials to recover from it, read a health department statement. Such facilities to treat this black fungus will be set up in six other cities: Mysuru, Shivamogga, Kalaburagi, Hubballi, Mangaluru and Belagavi.

In a corresponding development, Deputy Chief Minister Dr CN Ashwathnarayan said the state government is exploring collaboration with global alliance partners to procure critical drugs like Amphotericin B to treat black fungus; Remdesivir and Tocilizumab for treating COVID-19 patients.

The Dy CM who heads the state's COVID-19 task force, said balancing health with social and economic concerns is a huge challenge amid lockdowns and other pandemic-induced restrictions. He emphasized that collaborative efforts shall help all stakeholders t deal with the pandemic.  Australia, Britain, Canada, Denmark, Germany, the Netherlands, Israel, Japan, South Korea, Switzerland and the US are among the global alliance partner countries.

Related Stories

No stories found.
The News Minute
www.thenewsminute.com